📈 Ipamorelin protocol

Educational purposes only — not medical advice.
Ipamorelin is not FDA-approved and does not have official human dosing guidelines for wellness, recovery, or body-composition use.

⸻

Lesson 1: What Is Ipamorelin?

Ipamorelin is a growth hormone secretagogue.

That means it is studied for its ability to signal the body to release pulses of its own growth hormone. It works through the ghrelin / growth hormone secretagogue receptor pathway, rather than being actual HGH. Early studies describe Ipamorelin as a selective GH-releasing peptide.

Researchers study it for:

✅ Growth hormone signaling
✅ Recovery research
✅ Sleep-quality support research
✅ Lean-mass and body-composition research
✅ Healthy aging and repair pathways

⸻

Lesson 2: What Makes It Different?

Ipamorelin is often compared to compounds like GHRP-2 or GHRP-6.

The major appeal in research is that Ipamorelin appears more selective for GH release and is commonly discussed as having less impact on cortisol, prolactin, and hunger signaling compared with some older GHRPs. Growth hormone secretagogues as a category are still being studied for potential effects on body composition, appetite, lean mass, and metabolic health.

Simple version:

HGH = direct growth hormone
Ipamorelin = signals GH release (natural)

⸻

Lesson 3: Common Protocols

⏱️ Standard Daily Dosing

Because Ipamorelin has a relatively short biological half-life (~2 hours), timing and systemic consistency are crucial to achieving a therapeutic growth hormone pulse.

📏 Standard Dose Range: 100 mcg to 300 mcg per injection.
🔁 Frequency Options:
- Once Daily: A single 200–300 mcg injection taken right before bedtime. (Most common for fat loss, deep sleep, and general anti-aging support).
- Twice Daily: 100–150 mcg in the morning (fasted) and another 100–150 mcg at bedtime. (Preferred for accelerated athletic recovery or lean muscle tissue support).
📅 The 5/2 Schedule: To protect pituitary health, protocols widely use a 5-days-on, 2-days-off weekly routine. This temporary pause prevents receptor desensitization and allows the natural endocrine axis to rest.

🚫 The Strict Fasting Rule

Ipamorelin is highly sensitive to blood glucose and insulin levels.

🥩 Why it matters: Ingesting carbohydrates or fats triggers an insulin spike and elevates somatostatin (the growth hormone-inhibiting hormone), which will severely blunt or completely cancel out the peptide's ability to signal a GH pulse.
⏰ The Window: Injections must be taken on a completely empty stomach—at least 2 to 3 hours after the last meal. Following the subcutaneous shot, food should be avoided for at least 30 to 60 minutes to let the pulse peak naturally.

🤝 The Ultimate Combo: Stacking with CJC-1295 (No DAC)

In clinical research, Ipamorelin is rarely run completely by itself; it is most famously combined with CJC-1295 (No DAC)—also known as Modified GRF 1-29.

💥 The Synergistic Punch: Ipamorelin mimics ghrelin to release the brake on GH storage, while CJC-1295 acts as a Growth Hormone Releasing Hormone (GHRH) to amplify the actual signal strength of the pulse. When taken together, they produce a synergistic growth hormone release that is significantly stronger than what either peptide can achieve alone.
🧪 The Blend Protocol: They are typically reconstituted or bought together in an equal 1:1 ratio blend. A single subcutaneous injection delivers 100 mcg of CJC-1295 + 100 mcg of Ipamorelin simultaneously, following the exact same fasting and bedtime schedules.

⏳ Cycle Length & Breaks

🛠️ On-Cycle Phase: Ran continuously for 8 to 12 weeks. Measurable shifts in deep slow-wave sleep and recovery are noted in weeks 1–2, while body composition changes (abdominal fat loss and lean mass shifts) take 4–8 weeks to visibly surface.
🛑 Off-Cycle Phase: A mandatory 4 to 8-week break is taken between cycles to ensure long-term pituitary sensitivity.
💉 Site Rotation: Rotate subcutaneous injections daily across the abdominal fat pad, upper thigh, or love handles to maintain optimal tissue absorption and prevent local skin redness.

Many researchers discuss evening use because GH pulses naturally relate to sleep patterns, but timing varies by protocol.

⸻

Lesson 4: When To Increase

Researchers may consider increasing only when:

✅ The starting amount is well tolerated
✅ No swelling, tingling, headache, or blood sugar issues occur
✅ Sleep/recovery goals are not being met
✅ Nutrition and training are already consistent
✅ No other new compounds were added at the same time

A simple rule:

Do not increase fast. Ipamorelin is usually studied for signaling over time, not a strong immediate effect.

⸻

Lesson 5: When To Stop Increasing

Stop increasing when:

* Sleep and recovery improve
* Desired research response is reached
* Water retention appears
* Numbness or tingling appears
* Headaches increase
* Blood sugar issues appear
* Higher amounts do not improve results

For many protocols, the best range is the lowest effective amount, not the highest amount.

⸻

Lesson 6: Common Side Effects To Watch For

Researchers commonly watch for:

* Headache
* Flushing
* Dizziness
* Fatigue
* Water retention
* Tingling or numbness
* Increased hunger in some users
* Injection-site irritation
* Changes in blood glucose

Because Ipamorelin affects GH signaling, researchers should also be cautious in subjects with diabetes risk, active cancer history, severe edema, or uncontrolled metabolic disease.

⸻

Lesson 7: Important Safety Notes

The FDA has listed safety concerns around certain compounded peptide bulk substances, including Ipamorelin, and notes serious adverse events were reported when Ipamorelin was administered intravenously for gastric motility research. The FDA also states it lacks enough safety information to know whether other injectable routes could cause harm in humans.

Use extra caution with:

* Pregnancy or breastfeeding
* Active cancer or cancer history
* Diabetes or poor glucose control
* Severe edema or heart failure
* Severe kidney or liver disease
* Combining multiple GH-related compounds
* Unknown-source products

Seek medical help for chest pain, trouble breathing, severe swelling, fainting, allergic reaction, severe headache, vision changes, or signs of infection.

⸻